Date Title Description PDF
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download

Pages

Date Title Description PDF
17 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 10 May and 16 May 2024 Download
10 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 2 May and 9 May 2024 Download
08 May 2024 Announcement of General Shareholders’ Meeting The Company announces the decision of its Board of Directors to convene the Ordinary General Shareholders' Meeting Download
30 Apr 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 26 April and 30 April 2024 Download
26 Apr 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 19 April and 25 April 2024 Download

Pages

Date Title Description PDF
29 Apr 2015 Otros sobre Gobierno Corporativo Download
26 Feb 2015 Información sobre resultados (2) Download
26 Feb 2015 Información sobre resultados Download
26 Feb 2015 Informe anual de remuneraciones de los consejeros Download
26 Feb 2015 Composición del Consejo de Administración Download

Pages